Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoshi Zhang

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Optics Express|May 4, 2026
Real-time detection of multiple trace gases using fiber Bragg gratings combined with gas ionizationYing-Gang Nan, Yinping Sun, Bianli Zhao, et al.
BMC Cancer|May 5, 2018
Vemurafenib in Chinese patients with BRAF<sup>V600</sup> mutation-positive unresectable or metastatic melanoma: an open-label, multicenter phase I studyLu Si, Xiaoshi Zhang, Zhen Xu, et al.
Molecular Medicine Reports|March 5, 2015
Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivoWeiyuan Wei, Lei Li, Xiaotong Wang, et al.
Thoracic Cancer|July 10, 2020
Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinomaXiaoshi Zhang, Lutao Du, Jingyi Han, et al.
Scientific Reports|June 10, 2022
Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapyFuxue Huang, Jingjing Li, Xizhi Wen, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2017
The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case seriesXizhi Wen, Ya Ding, Jingjing Li, et al.
Frontiers in Immunology|December 26, 2022
An immune risk score predicts progression-free survival of melanoma patients in South China receiving anti-PD-1 inhibitor therapy-a retrospective cohort study examining 66 circulating immune cell subsetsPeidong Chi, Hang Jiang, Dandan Li, et al.
Oncotargets and Therapy|May 16, 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failureWei Xiao, Yi Que, Ruiqing Peng, et al.
Scientific Reports|January 24, 2023
Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancerAilin Qu, Qian Wang, Qing Chang, et al.
Nature Communications|July 1, 2025
Ultra-broadband ptychography for dispersive samplesHuixiang Lin, Angyi Lin, Xiaoyu Jin, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Optics Express|May 4, 2026
Real-time detection of multiple trace gases using fiber Bragg gratings combined with gas ionizationYing-Gang Nan, Yinping Sun, Bianli Zhao, et al.
BMC Cancer|May 5, 2018
Vemurafenib in Chinese patients with BRAF<sup>V600</sup> mutation-positive unresectable or metastatic melanoma: an open-label, multicenter phase I studyLu Si, Xiaoshi Zhang, Zhen Xu, et al.
Molecular Medicine Reports|March 5, 2015
Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivoWeiyuan Wei, Lei Li, Xiaotong Wang, et al.
Thoracic Cancer|July 10, 2020
Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinomaXiaoshi Zhang, Lutao Du, Jingyi Han, et al.
Scientific Reports|June 10, 2022
Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapyFuxue Huang, Jingjing Li, Xizhi Wen, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2017
The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case seriesXizhi Wen, Ya Ding, Jingjing Li, et al.
Frontiers in Immunology|December 26, 2022
An immune risk score predicts progression-free survival of melanoma patients in South China receiving anti-PD-1 inhibitor therapy-a retrospective cohort study examining 66 circulating immune cell subsetsPeidong Chi, Hang Jiang, Dandan Li, et al.
Oncotargets and Therapy|May 16, 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failureWei Xiao, Yi Que, Ruiqing Peng, et al.
Scientific Reports|January 24, 2023
Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancerAilin Qu, Qian Wang, Qing Chang, et al.
Nature Communications|July 1, 2025
Ultra-broadband ptychography for dispersive samplesHuixiang Lin, Angyi Lin, Xiaoyu Jin, et al.
Pageof 9